drugset / Trial / NCT06459063

Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint

NCT06459063 ↗

Phase 1/2 Active not recruiting 46 enrolled Kaplan Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a single center trial to assess the safety and efficacy of intra-articular administration of Allocetra to patients with 1st CMC thumb joint osteoarthritis (OA).

Timeline

Start
2024-06-10
Primary completion
2026-09
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allocetra Cell therapy — Other

Indications